Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Arizona State University | OTHER |
| Hanger Clinic: Prosthetics & Orthotics | OTHER |
Not provided
Not provided
A trial to compare the performance of the SoftHand Pro (SHP) and Ossur i-Limb in people with transradial limb loss over an 8-week period.
This study will measure improvements in outcomes obtained from laboratory testing of the SHP and i-Limb from baseline to after 8 weeks of daily use. A secondary analysis will incorporate the subjects' existing prosthetic hands. Finally, surveys and usage data collected through the SHP and i-Limb firmware during daily use will complement data the aforementioned outcomes to explore factors that may be related to differences in grasping and manipulation performance.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Initial Assignment: SoftHand Pro | Experimental | This arm of the crossover design will begin the trial using the SoftHand Pro. |
|
| Initial Assignment: Ossur i-Limb | Active Comparator | This arm of the crossover design will begin the trial using the i-Limb. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| SoftHand Pro | Device | Performance assessments utilizing the SoftHand Pro over an 8-week period. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Upper Extremity Functional Ability [1] | Change in upper extremity function, as measured by the Activities Measure for Upper Limb Amputees (AM-ULA). Participants complete 17 tasks, rated on task completion, speed of completion, movement quality, skillfulness of prosthesis use, and independence from the use of other assistive devices or adaptive environments with the prosthesis. The scale is 0 to 4, with a higher number representing higher performance in each category. Scores in each category are averaged for a Grade in each task. Grades for the 17 tasks are averaged and multiplied by 40 for a final score of 0 - 40, with a higher number representing higher overall function. | 8 Weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Upper Extremity Functional Ability [2] | Change in upper extremity function, as measured by the Action Research Arm Test (ARAT). Participants perform up to 19 tasks categorized by grasp, grip, pinch, and gross movement. The scale is 0 to 3, with a higher number representing higher performance in each category. Categories are scored separately. | 8 Weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Prosthesis User Preference | Changes in participants' perception of the utility, functional performance, ergonomics, and ease of use of their currently-used prosthesis, as measured by a custom Active Use questionnaire. Participants rate the extent to which they agree to 12 to 14 statements (depending of which prosthesis) on a 1 to 10 scale, with higher ratings representing closer agreement. Individual statements are assessed separately (no overall score). |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Marco Santello, Ph.D. | Arizona State University | Principal Investigator |
| Kristin D. Zhao, Ph.D. | Mayo Clinic | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Arizona State University | Tempe | Arizona | 85281-9709 | United States | ||
| Mayo Clinic |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| ICF | No | No | Yes | Informed Consent Form | Jun 2, 2025 | Jun 1, 2026 | ICF_000.pdf |
Not provided
| ID | Term |
|---|---|
| D001134 | Arm Injuries |
| D038062 | Upper Extremity Deformities, Congenital |
| D000673 | Amputation, Traumatic |
| C565682 | Amputation, Congenital |
| ID | Term |
|---|---|
| D014947 | Wounds and Injuries |
| D017880 | Limb Deformities, Congenital |
| D009139 | Musculoskeletal Abnormalities |
| D009140 | Musculoskeletal Diseases |
Not provided
Not provided
Crossover design with first intervention randomized.
Not provided
Not provided
Not provided
Not provided
| Ossur i-Limb | Device | Performance assessments utilizing the i-Limb over an 8-week period. |
|
| Upper Extremity Manual Dexterity | Change in upper extremity gross manual dexterity, as measured by the Box and Blocks test. Participants are tested in a timed transfer of blocks from one side of a box to another side over a low partition. A higher number of blocks successfully transferred during the timed episode represents a higher level of upper extremity manual dexterity. | 8 Weeks |
| Hand Motor Function | Change in fine and gross motor hand function, as measured by the Jebsen-Taylor Hand Function Test. Participants are timed in seven activities of daily living closely involving use of the hand, with a lower number of seconds required to complete the task representing a higher level of motor hand function. | 8 Weeks |
| Occupational Performance | Change in participants' perceived occupational performance, as measured by the Canadian Occupational Performance Measure (COPM). Participants choose up to 5 occupational performance problems; their perception of their own performance and their satisfaction with their performance regarding each problem is measured on a 1 to 10 scale, with higher scores representing higher performance and satisfaction. The difference in performance and satisfaction is calculated, and then the differences for all problems together are totaled and averaged, with the average divided by the number of problems establishing the final score for each performance and satisfaction. Higher averages represent better perceived performance and satisfaction. | 8 Weeks |
| Quality of Life | Change in participants' perceived quality of life, as measured by the the World Health Organization Quality of Life Disabilities Module (WHOQOL-DIS). Participants answer qualitative questions regarding patient activities, independence, and overall quality of life on a 1 to 5 scale, with a higher number indicating a higher concurrence or frequency related to the item in question, and totaled for a score which categorizes patient quality of life. | 8 Weeks |
| Upper Extremity Function and Pain | Change in participants' perceived levels of upper extremity physical function and symptoms, as measured by the Disabilities of the Arm, Shoulder, and Hand Score (QuickDASH). Participants rate their difficulty with examples of physical function and their severity of physical symptoms on a 1 to 5 scale, with higher values representing more severe difficulties and symptoms. The scores are combined in a calculation which results in an overall score, with higher scores representing more severe overall difficulties and symptoms. | 8 Weeks |
| Overall Functional Performance | Change in participants' perceived functional performance, as measured by the Patient-Specific Functional Scale. Participants select 5 or more activities for which they perceive a problem, rating their own performance of that activity on a scale of 0 to 10, with higher values representing greater ability to perform the activity. The scores are totaled and divided by the number of tasks for an average score, with higher values representing better performance. | 8 Weeks |
| Prosthesis Overall Functional Utility | Change in participants' perception of the utility of their currently-used prosthesis, as measured by the Orthotics Prosthetics Users Survey - Upper Extremity Functional Status (OPUS). Participants rate the prosthetic's ease of use for a variety of daily activities, 23 of which are scored, on a 0 to 4 scale, with higher values representing easier use. Scores are totaled and converted to a 0 to 92 scale, with higher overall scores representing better functional utility with the prosthesis. | 8 Weeks |
| Arm Pain | Change in participants' levels of pain is measured for subjects who have pain due to brachial plexopathy or neuropathy. A visual analog pain scale (VAS) specific to the limb testing the experimental device will be administered prior to, and after, the clinical measures. The VAS scale is measured by the subject's own perspective by using a 0 to 10 scale, with zero indicating no pain and ten being intolerable pain. These baseline metrics will be compared with performance metrics obtained using the same tests delivered at the end of the daily-use period. | 8 Weeks |
| 8 Weeks |
| Rochester |
| Minnesota |
| 55905 |
| United States |
| D000013 | Congenital Abnormalities |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |